# 2026年2月14日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 有创通气ICU患者人机异步识别与严重程度分级的专家共识：一项改良德尔菲研究（SYNAPsE）

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41686209)
**期刊：** Intensive care medicine
**PMID：** 41686209
**DOI：** 10.1007/s00134-026-08328-2

### 第一部分 原文与翻译

**英文原标题：** Consensus on identifying and ranking ventilator asynchronies in invasively ventilated ICU patients: a modified Delphi study (SYNAPsE).

> **英文摘要：**
> PURPOSE: Despite extensive research, it remains unclear which patient-ventilator asynchronies are reliably detectable in clinical practice, most clinically relevant, and how they rank in severity. METHODS: Multiple-choice questions and 5-point Likert-scale statements were used in iterative Delphi rounds. Feedback was incorporated until stable consensus or dissensus was reached for all items. First series of rounds focused on identifying and classifying patient-ventilator asynchronies detectable from ventilator waveforms, second series assessed their associations with outcomes in three patient groups, and in the final rounds, asynchronies were ranked by severity within these patient groups and across three scenarios. RESULTS: In total, 11 panelists completed nine rounds. Consensus classified ineffective triggering, reverse triggering, double triggering, auto-triggering, insufficient flow, premature cycling, and delayed cycling as clinically relevant patient-ventilator asynchronies. Of these, auto-triggering and delayed cycling were deemed unlikely to be detectable using ventilator waveforms alone. Across all three patient groups, the panelists reached consensus that double triggering and ineffective triggering were the most clinically relevant. In acute respiratory distress syndrome, double triggering, ineffective triggering, and reverse triggering were all judged clinically relevant. In patients without acute respiratory distress syndrome and after cardiac surgery, asynchronies were classified as severe or mild and combined into two composite groups. CONCLUSION: This Delphi study provides a consensus-based framework for identifying and ranking patient-ventilator asynchronies at the bedside, highlighting those most likely to be clinically relevant and offering a structured approach to support monitoring, intervention, and future research.

> **中文摘要：**
> 目的：尽管已有广泛研究，但在临床实践中哪些人机异步是可以可靠检测到的、哪些最具临床相关性以及它们的严重程度如何排序，目前仍不明确。方法：在迭代德尔菲轮次中采用了多项选择题和5点李克特量表陈述。纳入反馈直至所有条目达成稳定的共识或分歧。第一系列轮次侧重于识别和分类可从呼吸机波形中检测到的人机异步；第二系列评估了它们在三类患者群体中与预后的关联；在最终轮次中，对这些患者群体内及三种场景下的异步进行了严重程度排序。结果：共有11名专家组成员完成了九轮调查。共识将无效触发、反向触发、双重触发、自动触发、流速不足、过早切换和延迟切换归类为具有临床相关性的人机异步。其中，自动触发和延迟切换被认为不太可能仅通过呼吸机波形进行检测。在所有三类患者群体中，专家组达成共识，认为双重触发和无效触发最具临床相关性。在急性呼吸窘迫综合征（ARDS）中，双重触发、无效触发和反向触发均被判定为具有临床相关性。在非ARDS患者及心脏手术后患者中，异步被分为严重或轻微，并合并为两个综合组。结论：本德尔菲研究为床边识别和排序人机异步提供了一个基于共识的框架，强调了那些最可能具有临床相关性的异步，并提供了一种结构化方法来支持监测、干预及未来研究。

### 第二部分 AI 大师评价

该研究通过SYNAPsE改良德尔菲法，填补了重症监测中人机异步（PVA）临床评估标准的空白。其核心价值在于不仅定义了具有临床意义的异步类型（如无效触发、双重触发等），还首次针对不同疾病状态（如ARDS与非ARDS）对异步的严重程度进行了分级排序。尽管样本专家规模较小，但其多轮次的深度共识为临床医师提供了标准化的床旁监测框架，有助于优化机械通气策略并指导未来相关预后的量化研究。

---

## 2. 金黄色葡萄球菌血流感染中多变的葡萄球菌凝血酶活性

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41685885)
**期刊：** The Journal of infectious diseases
**PMID：** 41685885
**DOI：** 10.1093/infdis/jiag012

### 第一部分 原文与翻译

**英文原标题：** Variable Staphylothrombin Activity in Staphylococcus aureus Bloodstream Infections.

> **英文摘要：**
> BACKGROUND: Although manipulation of host hemostasis is a central mechanism in Staphylococcus aureus virulence, clinically relevant phenotypes of S aureus coagulase activity and the variability thereof in the context of bloodstream infections are unknown. METHODS: We created a high-throughput staphylothrombin activity and growth fitness assay to characterize fibrin formation and S aureus replication by adding bacterial culture supernatant to human blood plasma. Supernatant is rich in bacterial proteins, including coagulases secreted during growth, but it contains relatively few viable cells. As a result, staphylothrombin activity driven by secreted coagulases can initially be observed and a contribution from bacterial replication can also be captured. RESULTS: Some S aureus isolates showed slow or absent staphylothrombin activity in a subset of plasma specimens despite robust and rapid fibrin polymerization in other plasmas, suggesting that a host-pathogen match or mismatch determines the observed phenotype. Characterization of S aureus transposon mutant behavior, host plasma coagulation factors, pharmacologic direct thrombin inhibition, and across-host patterns provides clues to complex determinants of coagulase-mediated virulence. CONCLUSIONS: Observations of variable staphylothrombin phenotypes may have implications for novel therapeutic approaches and clinical risk stratification in S aureus bloodstream infections.

> **中文摘要：**
> 背景：尽管操控宿主止血是金黄色葡萄球菌毒力的核心机制，但在血流感染背景下，金黄色葡萄球菌凝血酶活性的临床相关表型及其变异性尚不清楚。方法：我们创建了一种高通量葡萄球菌凝血酶活性和生长适应性检测方法，通过在人血浆中加入细菌培养上清液来表征纤维蛋白形成和金黄色葡萄球菌的复制。上清液富含细菌蛋白，包括生长过程中分泌的凝血酶，但包含的活细胞相对较少。因此，最初可以观察到由分泌的凝血酶驱动的葡萄球菌凝血酶活性，并且还可以捕捉到细菌复制带来的贡献。结果：一些金黄色葡萄球菌分离株在部分血浆样本中表现出缓慢或缺失的葡萄球菌凝血酶活性，尽管在其他血浆中表现出强健且快速的纤维蛋白聚合，这表明宿主-病原体的匹配或不匹配决定了所观察到的表型。对金黄色葡萄球菌转座子突变体行为、宿主血浆凝血因子、药理性直接凝血酶抑制以及跨宿主模式的表征，为凝血酶介导毒力的复杂决定因素提供了线索。结论：对多变葡萄球菌凝血酶表型的观察可能对金黄色葡萄球菌血流感染的新型治疗方法和临床风险分层具有重要意义。

### 第二部分 AI 大师评价

该研究开发了一种创新的高通量检测平台，旨在系统性地解析金黄色葡萄球菌在血流感染中通过分泌凝血酶操控宿主凝血系统的动态机制。研究重点发现，葡萄球菌凝血酶活性的发挥显著取决于宿主与病原体之间的匹配性，这一发现挑战了以往对细菌凝血活性的单一认知。通过整合转座子突变体分析与药理学抑制实验，该研究为理解金葡菌的毒力决定因素提供了多维视角，在临床风险分层和靶向凝血通路的辅助治疗方面具有重要的转化医学价值。

---

## 3. 室颤型心脏骤停现场选择性脑冷却：PRINCESS2随机对照试验的试点结果

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41680915)
**期刊：** Critical care (London, England)
**PMID：** 41680915
**DOI：** 10.1186/s13054-026-05851-y

### 第一部分 原文与翻译

**英文原标题：** On-scene selective brain cooling in ventricular fibrillation cardiac arrest: pilot results from the PRINCESS2 randomised trial.

> **英文摘要：**
> BACKGROUND: Although ischemia-reperfusion brain injury represents a major clinical problem after cardiac arrest, no neuroprotective treatment currently exists. The PRINCESS2 trial is designed to confirm previous findings, indicating that on-scene selective brain cooling using a portable trans-nasal cooling method improves complete neurological recovery after out-of-hospital cardiac arrest (OHCA) with initial shockable rhythms (e.g. ventricular fibrillation). This prespecified pilot phase aimed to assess protocol adherence and safety aspects for this early cooling strategy. METHODS: The prespecified pilot phase includes the first 100 patients in the main PRINCESS2 trial, an ongoing European multicentre trial enrolling 1,022 OHCA patients with initial shockable rhythm. Patients are randomised to intervention; trans-nasal cooling initiated at the scene of arrest followed by systemic hypothermia (33 ± 0.5 °C for 24 h) in the intensive care unit, or control; normothermia with fever control. Neuroprognostication and criteria for withdrawal of life-sustaining treatment are protocolised. Pilot outcomes were adherence to treatment allocation and protocol in the prehospital and in-hospital stages, and safety aspects, including 72-hour survival, prehospital re-arrest, device-related adverse events, and adverse events within 7 days such as bleeding, sepsis, arrhythmias with hemodynamic compromise, or need for circulatory support. RESULTS: In total, 100 patients were randomised (median age 64 years, 91% male) to intervention (n = 50) or control (n = 50). All intervention patients received allocated treatment. Four had minor trans-nasal cooling interruptions, and two had systemic cooling interruptions. Among controls, 48/50 received allocated treatment, while two crossed over to cooling. One control was lost to follow-up. Overall, adherence to allocation and treatment protocol was 92%. Survival to 72 h was similar (intervention: 32/50 [64%], control: 31/49 [63%]) as well as prehospital re-arrest rates (11/49 [22%] vs. 9/40 [23%]). No device-related serious adverse events occurred. Adverse event rates within 7 days were similar. CONCLUSION: In this pilot phase of the PRINCESS2 trial, on-scene trans-nasal cooling in OHCA patients with shockable rhythms was performed with high protocol adherence without safety concerns. The main trial will continue as planned.

> **中文摘要：**
> 背景：尽管缺血再灌注脑损伤是心脏骤停后的一个主要临床问题，但目前尚不存在神经保护治疗方法。PRINCESS2 试验旨在证实之前的发现，即针对初始为可电击心律（如心室颤动）的院外心脏骤停 (OHCA) 患者，使用便携式经鼻冷却法进行现场选择性脑冷却可改善神经功能的完全恢复。这一预设的试点阶段旨在评估该早期冷却策略的方案依从性和安全性。方法：预设的试点阶段包括 PRINCESS2 主试验的前 100 名患者，这是一项正在进行的欧洲多中心试验，共招募 1022 名初始为可电击心律的 OHCA 患者。患者被随机分配至干预组（在骤停现场启动经鼻冷却，随后在重症监护病房进行 24 小时 33 ± 0.5 °C 的全身低温治疗）或对照组（常温并进行发热控制）。神经预后评估和撤除维持生命治疗的标准均已方案化。试点结局指标包括院前和院内阶段对治疗分配及方案的依从性，以及安全性方面，包括 72 小时生存率、院前再次骤停、设备相关不良事件，以及 7 天内的不良事件（如出血、败血症、伴有血流动力学障碍的心律失常或需要循环支持）。结果：共有 100 名患者（中位年龄 64 岁，91% 为男性）被随机分配至干预组 (n = 50) 或对照组 (n = 50)。所有干预组患者均接受了分配的治疗。4 人出现了轻微的经鼻冷却中断，2 人出现了全身冷却中断。在对照组中，48/50 人接受了分配的治疗，而 2 人交叉进入冷却组。1 名对照组患者失访。总体而言，对分配和治疗方案的依从性为 92%。72 小时生存率相似（干预组：32/50 [64%]，对照组：31/49 [63%]），院前再次骤停率也相似（11/49 [22%] vs. 9/40 [23%]）。未发生设备相关的严重不良事件。7 天内的不良事件发生率相似。结论：在 PRINCESS2 试验的这一试点阶段，对具有可电击心律的 OHCA 患者进行现场经鼻冷却的实施具有较高的方案依从性，且无安全性顾虑。主试验将按计划继续进行。

### 第二部分 AI 大师评价

本研究展示了 PRINCESS2 试验的先导阶段成果，重点评估了在院外心脏骤停现场启动经鼻选择性脑冷却的可行性。研究结果显示，该超早期干预方案具有极高的协议依从性（92%）且未增加安全性风险，成功证实了在多中心急救环境下实施复杂物理降温技术的可行性。尽管试点规模不足以评估最终神经预后改善，但其严谨的流程管理和安全性数据为后续 1022 人的大规模临床试验奠定了坚实基础。

---

## 4. 低磷血症作为儿童重症监护病房（PICU）强化营养代谢不耐受的生物标志物：PEPaNIC 随机对照试验的二次分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41680910)
**期刊：** Critical care (London, England)
**PMID：** 41680910
**DOI：** 10.1186/s13054-026-05844-x

### 第一部分 原文与翻译

**英文原标题：** Hypophosphatemia as a biomarker of metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT.

> **英文摘要：**
> BACKGROUND: The PEPaNIC RCT showed that early supplementation of insufficient enteral nutrition by parenteral nutrition (early-PN) worsened outcome of critically ill children as compared with withholding PN for 1 week (late-PN). The best timing to initiate nutritional support in the pediatric intensive care unit (PICU) remains unclear. In adults, declining phosphate levels may identify patients who are particularly harmed by early-PN. We therefore assessed whether early hypophosphatemia in critically ill children may indicate metabolic intolerance to nutrition. METHODS: In this secondary analysis of the PEPaNIC RCT (n = 1440), we investigated whether development of hypophosphatemia statistically interacts with the randomized intervention for its impact on clinical outcome, adjusting for baseline risk factors. Outcomes of interest included the incidence of new infections and the duration of PICU dependency as primary endpoints, 90-day mortality as safety endpoint, and duration of mechanical ventilation and of hospital stay as secondary endpoints. Subsequently, the impact of early-PN vs. late-PN in patients with and without early hypophosphatemia was assessed. Analyses were performed for phosphate abnormalities on PICU day 1 and 2, with and without imputing 20.3% (day 1) or 22.0% (day 2) missing phosphate data. RESULTS: Of patients with available phosphate measurements, 19.9% (211/1060) and 27.5% (243/883) developed hypophosphatemia on day 1 and day 2, respectively. Day 1 hypophosphatemia did not interact with the randomized intervention for any studied outcome. On day 2, hypophosphatemia interacted with randomization for risk of new infection (P = 0.031), likelihood of earlier live PICU discharge (P = 0.030), and time to live weaning from mechanical ventilation (P = 0.025). Harm by early-PN was more pronounced in patients with hypophosphatemia than in those without. Results after imputing missing phosphate data were similar, with an additional interaction for 90-day mortality (P = 0.038) revealing higher mortality with early-PN in patients with hypophosphatemia. CONCLUSIONS: Development of hypophosphatemia may identify critically ill children who are particularly harmed by early-PN. This opens perspectives for its use as a biomarker of metabolic intolerance to enhanced nutrition, which requires further investigation.

> **中文摘要：**
> 背景：PEPaNIC 随机对照试验（RCT）显示，与延迟 1 周给予肠外营养（late-PN）相比，早期通过肠外营养补充不足的肠内营养（early-PN）会使危重患儿的预后恶化。目前尚不清楚在儿童重症监护病房（PICU）启动营养支持的最佳时机。在成人中，磷水平下降可能识别出受 early-PN 伤害特别严重的患者。因此，我们评估了危重患儿的早期低磷血症是否可能预示对营养的代谢不耐受。方法：在这项针对 PEPaNIC RCT（n = 1440）的二次分析中，我们调查了低磷血症的发生是否与随机干预措施在临床结局的影响上存在统计学交互作用，并对基线风险因素进行了调整。主要终点包括新发感染率和 PICU 依赖时长，安全性终点为 90 天死亡率，次要终点包括机械通气时间和住院时长。随后，评估了伴有和不伴有早期低磷血症患者中 early-PN 与 late-PN 的影响。针对 PICU 第 1 天和第 2 天的磷异常情况进行了分析，包括对 20.3%（第 1 天）或 22.0%（第 2 天）缺失的磷数据进行填补和未填补的情况。结果：在有可用磷测定数据的患者中，第 1 天和第 2 天分别有 19.9% (211/1060) 和 27.5% (243/883) 发生了低磷血症。第 1 天的低磷血症与任何研究结局的随机干预措施均无交互作用。在第 2 天，低磷血症与随机分组在新发感染风险（P = 0.031）、更早存活出院的可能性（P = 0.030）以及存活撤离机械通气的时间（P = 0.025）方面存在交互作用。在低磷血症患者中，early-PN 带来的危害比非低磷血症患者更为显著。填补缺失数据后的分析结果相似，且在 90 天死亡率方面观察到了额外的交互作用（P = 0.038），显示低磷血症患者接受 early-PN 后的死亡率更高。结论：低磷血症的发生可能识别出那些受 early-PN 伤害特别严重的危重患儿。这为其作为强化营养代谢不耐受的生物标志物开辟了前景，但仍需进一步研究。

### 第二部分 AI 大师评价

本研究通过对PEPaNIC大型随机对照试验的二次分析，严谨地探讨了危重症儿童在接受营养支持时磷代谢与临床预后的关系。核心发现在于，PICU入室第2天的低磷血症与早期肠外营养带来的不良临床后果（如感染增加、出院延迟及死亡率上升）具有显著的统计学交互作用。研究结果有力地证明了低磷血症可作为识别对强化营养代谢不耐受患儿的生物标志物，这对于优化PICU精准营养策略、避免早期过度营养造成的潜在伤害具有重要的临床指导意义。尽管作为二次分析存在一定的局限性，但其为重症患儿的营养代谢监测提供了高质量的循证证据。

---

## 5. 探讨内皮细胞Pim-1上调组织因子引发脓毒症高凝状态的机制

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41680610)
**期刊：** Molecular medicine (Cambridge, Mass.)
**PMID：** 41680610
**DOI：** 10.1186/s10020-026-01433-4

### 第一部分 原文与翻译

**英文原标题：** Exploring the mechanism of endothelial Pim-1 upregulation of tissue factor to initiate the hypercoagulable state in sepsis.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本研究聚焦于脓毒症引起的高凝状态，深入探讨了内皮细胞中Pim-1激酶调控组织因子（TF）表达的分子机制。研究揭示了Pim-1作为关键调节因子，在触发脓毒症相关凝血功能障碍中的核心作用，为理解败血症诱导的血栓形成提供了新视角。该发现不仅丰富了脓毒症血管内皮损伤的理论体系，也为开发针对Pim-1通路的精准抗凝治疗方案提供了潜在的生物标志物和干预靶点。

---

## 6. 慢性炎症中，组织驻留巨噬细胞的生存依赖于由 SerpinB2 调节的线粒体功能

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41680163)
**期刊：** Nature communications
**PMID：** 41680163
**DOI：** 10.1038/s41467-026-69196-4

### 第一部分 原文与翻译

**英文原标题：** Tissue-resident macrophage survival depends on mitochondrial function regulated by SerpinB2 in chronic inflammation.

> **英文摘要：**
> How cellular metabolism facilitates tissue-resident macrophage maintenance remains elusive. Here we show that visceral adipose tissue (VAT)-resident macrophages, unlike monocyte-derived macrophages, are enriched with mitochondrial-specific antioxidant enzymes restraining inflammation and promoting VAT homeostasis and insulin sensitivity. Additionally, VAT resident macrophages express high levels of plasminogen activator inhibitor type 2, encoded by SerpinB2, which is involved in the blood coagulation cascade. SerpinB2 promotes adipose resident macrophage survival by regulating mitochondrial oxidative phosphorylation and preventing the release of pro-apoptotic cytochrome c from the mitochondria into the cytoplasm via antioxidant glutathione production. Chronic inflammation, such as obesity, diminishes SerpinB2 expression in VAT macrophages in patients and mice, leading to the decline of this macrophage subset. Mechanistically, interferon-γ elevation in diabetes induces Ikaros, a transcriptional suppressor, which binds to the SerpinB2 promoter and decreases SerpinB2 expression. Congruently, selective depletion of the IFN-γ receptor in myeloid cells or supplementation of macrophage-specific SerpinB2 deficient mice with N-acetylcysteine, a glutathione precursor, restores VAT resident macrophage survival, decreases adipocyte size, and improves glucose tolerance and insulin sensitivity. Our data thus reveal an unexpected function of SerpinB2 in the regulation of mitochondrial function and survival of tissue-resident macrophages.

> **中文摘要：**
> 细胞代谢如何促进组织驻留巨噬细胞的维持仍不清楚。在此我们表明，与单核细胞衍生的巨噬细胞不同，内脏脂肪组织（VAT）驻留巨噬细胞富含线粒体特异性抗氧化酶，这些酶能抑制炎症并促进 VAT 稳态和胰岛素敏感性。此外，VAT 驻留巨噬细胞高表达 2 型纤溶酶原激活物抑制剂（由 SerpinB2 编码），该蛋白参与血液凝固级联。SerpinB2 通过调节线粒体氧化磷酸化，并通过产生抗氧化谷胱甘肽来防止促凋亡细胞色素 c 从线粒体释放到细胞质中，从而促进脂肪驻留巨噬细胞的存活。慢性炎症（如肥胖）会减少患者和小鼠 VAT 巨噬细胞中 SerpinB2 的表达，导致该巨噬细胞亚群的减少。从机制上讲，糖尿病中干扰素-γ 的升高会诱导转录抑制因子 Ikaros，其结合 SerpinB2 启动子并降低 SerpinB2 的表达。一致地，选择性敲除髓系细胞中的 IFN-γ 受体，或为巨噬细胞特异性 SerpinB2 缺陷小鼠补充谷胱甘肽前体 N-乙酰半胱氨酸，可恢复 VAT 驻留巨噬细胞的生存，减小脂肪细胞体积，并改善糖耐量和胰岛素敏感性。我们的数据由此揭示了 SerpinB2 在调节线粒体功能和组织驻留巨噬细胞生存中一种意想不到的功能。

### 第二部分 AI 大师评价

本研究深入探讨了内脏脂肪组织驻留巨噬细胞在慢性炎症环境下的生存机制，重点阐述了 SerpinB2 通过维持线粒体氧化磷酸化和抗氧化稳态（谷胱甘肽产生）来防止细胞凋亡的关键作用。研究揭示了 IFN-γ/Ikaros 轴介导的 SerpinB2 下调是肥胖诱导的巨噬细胞流失及胰岛素抵抗的核心因素。该发现不仅拓展了对 SerpinB2 传统凝血功能之外的生物学认识，还为治疗肥胖相关的代谢紊乱提供了基于恢复巨噬细胞线粒体功能的新策略，具有显著的科学创新性和临床转化潜力。

---

## 7. 非洲高风险人群队列中抗病毒免疫和炎症通路的变异先于 HIV-1 感染

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41678285)
**期刊：** The Journal of clinical investigation
**PMID：** 41678285
**DOI：** 10.1172/JCI195172

### 第一部分 原文与翻译

**英文原标题：** Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort.

> **英文摘要：**
> BACKGROUND: Susceptibility to human immunodeficiency virus type 1 (HIV-1) infection varies between individuals, but the biological determinants of acquisition risk remain poorly defined. METHODS: We conducted a case-control study nested within a high-risk cohort in Kenya. We compared the plasma extracellular RNA collected before HIV-1 acquisition with matched uninfected controls to identify immunological processes linked to infection risk. RESULTS: Individuals who later acquired HIV-1 exhibited upregulation of immune processes that facilitate viral infection, including T cell suppression, type II interferon and Th2 immune responses. In contrast, processes associated with antiviral defence and tissue repair, such as neutrophil and natural killer cell responses, type I interferon responses, wound healing, and angiogenesis, were downregulated. CONCLUSION: These findings highlight dampened antiviral immunity prior to exposure as a correlate of increased risk for subsequent HIV-1 acquisition.

> **中文摘要：**
> 背景：个体对人类免疫缺陷病毒 1 型（HIV-1）感染的易感性存在差异，但关于获得感染风险的生物学决定因素仍未得到明确界定。方法：我们在肯尼亚的一个高风险队列中进行了一项嵌套病例对照研究。通过比较 HIV-1 感染前收集的血浆胞外 RNA 与匹配的未感染对照组，以识别与感染风险相关的免疫过程。结果：随后感染 HIV-1 的个体表现出促进病毒感染的免疫过程上调，包括 T 细胞抑制、II 型干扰素和 Th2 免疫反应。相比之下，与抗病毒防御和组织修复相关的过程（如中性粒细胞和自然杀伤细胞反应、I 型干扰素反应、伤口愈合和血管生成）则表现为下调。结论：这些发现强调了暴露前抗病毒免疫功能的减弱是随后 HIV-1 感染风险增加的相关因素。

### 第二部分 AI 大师评价

本研究通过对肯尼亚高风险队列进行嵌套病例对照分析，利用血浆胞外 RNA 测序技术揭示了 HIV-1 易感性的预存生物学标志物。研究发现，在病毒暴露发生之前，易感个体的免疫系统已呈现出促病毒环境（如 T 细胞抑制及 II 型干扰素上调）与抗病毒/修复功能减弱（如 I 型干扰素及 NK 细胞反应下调）的失衡状态。这一发现突破了感染风险仅取决于暴露行为的传统认识，为识别高危个体及开发基于免疫调节的预防策略提供了重要的分子依据，其临床价值在于为精准预防 HIV-1 提供了新的靶点。

---

速递结束，祝您工作愉快！